Improved detection of recurrent bladder cancer using the bard bta stat test
β Scribed by Michael F. Sarosdy; M'Liss A. Hudson; William J. Ellis; Mark S. Soloway; Ralph deVere White; Joel Sheinfeld; Mark V. Jarowenko; Paul F. Schellhammer; Ed W. Schervish; Jay V. Patel; Gerald W. Chodak; Donald L. Lamm; Robert D. Johnson; Mary Henderson; George Adams; Brent A. Blumenstein; Kent R. Thoelke; Randy D. Pfalzgraf; Heather A. Murchison; Sharon L. Brunelle
- Book ID
- 119486932
- Publisher
- Elsevier Science
- Year
- 1997
- Tongue
- English
- Weight
- 690 KB
- Volume
- 50
- Category
- Article
- ISSN
- 0090-4295
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Our study evaluated the BTA (bladder tumor antigen) stat test kit as a primary screening device for the detection of transitional-cell carcinoma (TCC) of the bladder, with direct comparison by voided urine cytology (VUC) on the same specimens. The unfixed voided urine of 100 patients with no history